YM BioSciences Inc.
http://www.ymbiosciences.com
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From YM BioSciences Inc.
Keeping Track: US FDA Okays Alnylam’s siRNA Amvuttra, Alopecia Claim For Lilly’s Olumiant; Sierra Submits Momelotinib
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
Globus Medical Completes First Surgery With Excelsius Imaging System
Globus Medical CFO Keith Pfeil said “enthusiasm is great” with “more than double-digit orders” for the Excelsius3D system.
Execs On The Move: April 2022
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
At Hard-Hit Gene Therapy Company Freeline, CEO Believes A Turnaround Is Possible
Michael Parini talks to Scrip about how a new focus at the company can help it prove the value of its AAV-based gene therapy platform.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
- Other Names / Subsidiaries
-
- Cytopia Limited